- Home
- ECAT vs AZTA Comparison
ECAT vs AZTA Comparison
Compare ECAT & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ECAT | AZTA |
|---|---|---|
| Founded | 2021 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Machinery/Components |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ECAT | AZTA |
|---|---|---|
| Price | $14.08 | $34.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $40.60 |
| AVG Volume (30 Days) | 566.2K | ★ 674.1K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 9.20% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $593,821,000.00 |
| Revenue This Year | N/A | $6.99 |
| Revenue Next Year | N/A | $5.98 |
| P/E Ratio | $6.32 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.36 | $15.93 |
| 52 Week High | $16.73 | $41.73 |
Technical Indicators
Market Signals| Indicator | ECAT | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 35.43 | 58.80 |
| Support Level | $13.79 | $33.39 |
| Resistance Level | $15.79 | $37.49 |
| Average True Range (ATR) | 0.27 | 0.99 |
| MACD | -0.04 | 0.15 |
| Stochastic Oscillator | 24.54 | 79.58 |
Price Performance
Historical ComparisonAbout ECAT BlackRock ESG Capital Allocation Term Trust of Beneficial Interest
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.
About AZTA Azenta Inc.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.